Concepedia

Author

Andrea R. Hagemann

Washington University in St. LouisORCID

Also Known As

A Hagemann, A. Hagemann, A. R. Hagemann, A.R. Hagemann, Andrea Hagemann, Andrea R Hagemann, Andrea R. Hagemann, Andrea R. Hagemann

417

Publications

4K

Citations

29

H-Index

111

Concepts

All Affiliations

Washington University in St. LouisUniversity of PennsylvaniaBarnes-Jewish HospitalMemorial Sloan Kettering Cancer CenterAlvin J. Siteman Cancer Center
AR

About

Andrea R. Hagemann is an author at Washington University in St. Louis specializing in medicine, obstetrics, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

21

30

1.2K

2

Public Health

4

4

259

3

Health Sciences

3

3

100

4

Engineering

1

1

27

5

Nursing

1

1

13

Andrea R. Hagemann

×

62

Publications

3.7K

Citations

28

H-Index

YearCitations

Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer

Robert L. Coleman, Gini F. Fleming, Mark F. Brady,

New England Journal of Medicine

2019

886

Randomized Phase II Trial of Nivolumab Versus Nivolumab and Ipilimumab for Recurrent or Persistent Ovarian Cancer: An NRG Oncology Study

Dmitriy Zamarin, Robert A. Burger, Michael W. Sill,

Journal of Clinical Oncology

2020

329

NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024

Mary B. Daly, Tuya Pal, Kara N. Maxwell,

Journal of the National Comprehensive Cancer Network

2023

249

A Dendritic Cell Vaccine Pulsed with Autologous Hypochlorous Acid-Oxidized Ovarian Cancer Lysate Primes Effective Broad Antitumor Immunity: From Bench to Bedside

Cheryl Lai-Lai Chiang, Lana E. Kandalaft, János L. Tanyi,

Clinical Cancer Research

2013

215

Social approach–avoidance behavior of inbred mouse strains towards DBA/2 mice

Edward S. Brodkin, Andrea R. Hagemann, Sondra Maureen Nemetski,

Brain Research

2004

169

Bevacizumab combination therapy in recurrent, platinum‐refractory, epithelial ovarian carcinoma

Jason D. Wright, Andrea R. Hagemann, Janet S. Rader,

Cancer

2006

130

Positive peritoneal cytology is an independent risk-factor in early stage endometrial cancer

Gunjal Garg, Feng Gao, Jason D. Wright,

Gynecologic Oncology

2012

128

Characterization of the CRISPR/Cas Subtype I-A System of the Hyperthermophilic Crenarchaeon Thermoproteus tenax

Alexandra Plagens, Britta Tjaden, Andrea R. Hagemann,

Journal of Bacteriology

2012

111

FIGO 2018 staging criteria for cervical cancer: Impact on stage migration and survival

Perry W. Grigsby, L. Stewart Massad, David G. Mutch,

Gynecologic Oncology

2020

101

Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, and Gastric, Version 3.2024, NCCN Clinical Practice Guidelines In Oncology

Rachel Hodan, Samir Gupta, Jennifer M. Weiss,

Journal of the National Comprehensive Cancer Network

2024

69

Page 1